Periodontitis is a chronic, inflammatory condition in the tissues surrounding teeth that is stimulated by dental plaque bacteria and results in the destruction of tooth supporting tissues. Type 2 diabetes is associated with an increased prevalence and severity of periodontitis that is related to underlying glycaemic control. It has been suggested that the presence of chronic periodontal inflammation has a converse and negative effect on glycaemic control in diabetes with most evidence emerging from studies of type 2 diabetes. This article reviews the evidence from cohort, prospective and meta-analysis studies that have been conducted to examine the relationship between periodontitis and glycaemic control in type 2 diabetes and suggests underlying pathogenic mechanisms that may explain the relationship between these conditions.
Periodontitis is a bacteria-related, chronic inflammation that results in destruction of the bone and connective tissue support of teeth forming periodontal pockets between the tooth and gingival soft tissue. 1 It is initiated by inadequate oral hygiene and the development of a biofilm colonised with pathogenic bacteria on the tooth surface that results in direct damage to local tissues by bacterial virulence factors (see Figures 1 and 2 ). 2 The stimulation, an inflammatory/immune response to the offending bacteria, is further associated with indirect tissue damage 3,4 mediated by cytokines including interleukin-1 beta (IL-1β), 5 IL-6, tumour necrosis factor-alpha (TNF-α) prostaglandins and collagenolytic enzymes. 6, 7 Oxidative damage to the tissues is also a feature of the periodontitis lesion, 8, 9 thought to result from hyper-reactive neutrophils generating excessive reactive oxygen species (ROS) during bacterial phagocytosis 10 causing both direct damage and stimulating redox-sensitive pro-inflammatory transcription factors.
Individuals vary in their susceptibility to periodontitis and the key determinant appears to be a phenotype coding for a particularly exaggerated inflammatory and immune response to pathogenic bacteria. 11 Within worldwide populations, periodontitis is a common condition with a prevalence of between 5 to 20 %. 12 The rate of progression varies among individuals but the most common form of the disease has a chronic, slowly progressing nature and patients may be burdened by the chronic inflammatory condition for years or decades before diagnosis and treatment.
Progression of untreated periodontitis can result in pain, aesthetic problems, functional difficulties and complete tooth loss in severe cases.
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Systemic Effects of Periodontitis
There is evidence of an 'over-spill' from chronic periodontal lesions to more peripheral tissues; plasma levels of periodontitis-associated markers including IL-6, TNF-α, and high-sensitivity C-reactive protein (hsCRP) are elevated 14, 15 and systemic oxidative status is compromised in patients with periodontitis compared with healthy controls. [16] [17] [18] Indeed, pro-inflammatory cytokines released at the diseased periodontal site 19, 20 translocating to distant sites via the circulation, are thought to induce changes in vascular endothelium and increase the risk for cardiovascular disease. 21, 22 A recent cross-sectional study of more than 6,000 adults reported that participants with diabetes and periodontitis had an increased likelihood of intimal media thickening and coronary heart disease (CHD). 23 Periodontal treatment lowers systemic levels of inflammatory markers 24 and improves haemostatic parameters in cardiac patients.
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Diabetes and Periodontitis
There is substantial evidence from cross-sectional and prospective studies that people with types 1 and 2 diabetes have more than double the risk of developing periodontitis; [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] reviewed by Taylor and Borgnakke. 37 Diabetes can also result in more severe periodontal destruction than in matched non-diabetes groups. 38, 39 The increased risk for periodontitis is dependent on glycaemic control 40 and not the duration of diabetes. 
The Impact of Periodontitis on Glycaemic Control
A bi-directional relationship between periodontitis and type 2 diabetes has been suggested with the presence of chronic periodontitis thought to have a reciprocating negative effect on diabetes control.
Early evidence came from studies in a distinct population group of Pima Indians who have a very high prevalence of type 2 diabetes. These studies indicated that severe periodontal inflammation was predictive of a greater deterioration in glycaemic control over time compared with a non-periodontitis group, 42 and was a strong predictor of mortality from the common diabetes-associated complications of ischaemic heart disease and diabetic nephropathy. 43 HbA 1c (≥6.5 %) over the five years was increased 2-3 fold, depending on the severity of the periodontal lesion at baseline. 49 Periodontitis was also associated with increased risk for diabetes incidence in a seven-year prospective study of 5,848 non-diabetic individuals but significance was lost when adjusting for confounding factors. 50 HbA 1c levels correlated with the surface area of the inflamed periodontal lesions and therefore the extent of periodontal inflammation in one study conducted within a type 2 diabetes group. 51 Some studies have examined the relationship between periodontal condition and plasma glucose levels; non-diabetics with periodontitis are reported to have higher resting plasma glucose and HbA 1c levels than matched controls. [52] [53] [54] Analysis of data from 12,254 participants in the Third National Health and Nutrition Examination Survey (NHANES III), showed that participants with the most severe periodontal destruction had an increased odds ratio for both impaired fasting glucose (≥100 but <126 mg/dl) and diabetes (≥126 mg/dl) after adjustment for potential confounders. 55 Animal studies (while limited in their ability to provide direct evidence applicable to humans) have confirmed the destabilisation of glycaemic control by periodontal inflammation. Periodontitis is readily initiated in Wistar rats by the tying of ligatures around teeth for a period of weeks. These periodontitis rats (PD rats) had increased blood glucose compared with non-PD rats. 56 The precise mechanism underlying the effect on glycaemic control by periodontal inflammation has been investigated using this
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The Impact of Periodontal Therapy on Diabetes Status
The results from the earliest treatment studies are limited as they were conducted within the Pima Indian group 58 Therefore, periodontal therapy appears to be more successful in improving glycaemic control in type 2 diabetes.
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Potential Mechanisms Underlying the Bi-directional Relationship Between Periodontitis and Diabetes
The precise relationship between diabetes and periodontitis remains unclear but the increased risk for periodontitis in diabetes patients may be due to a change in the local periodontal environment, either because of glycation of proteins (including collagen) making them more susceptible to breakdown 74, 75 or increased oxidative stress and an associated pro-inflammatory stimulus. 76 Recent treatment studies have explored a wider range of clinical parameters in an effort to uncover more knowledge and have focused on inflammatory markers as both periodontitis and type 2 diabetes are known to have an underlying state of hyper-inflammation. Higher levels of CRP were detected in a group with type 2 diabetes and periodontitis at levels that could not be explained by either of the conditions alone, suggesting a synergystic pro-inflammatory stimulus when these conditions co-exist. 77 The role of TNF-α has been
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particularly explored because it is elevated in periodontitis 78 and is associated with insulin resistance, mediated by serine phosphorylation of the insulin receptor. 79 A state of underlying oxidative stress is known to exist in both periodontitis and diabetes 76 due to hyperactive neutrophils in periodontitis, 16 and generated within cellular mitochondria in hyperglycaemic conditions. 82 Oxidative stress directly stimulates pathways associated with pro-inflammatory cytokine production, 77 insulin resistance 83 and diabetes complications, [84] [85] [86] and may be a central pathological feature leading to an amplification of inflammatory processes when both chronic periodontitis and type 2 diabetes co-exist. 87 Further investigations into the role of the oxidative stress/inflammation axis may suggest novel therapeutic strategies in the management of periodontitis and diabetes.
Conclusion
Periodontal inflammation appears to have a de-stabilising effect on glycaemic control in type 2 diabetes and a clinically significant reduction in HbA 1c of approximately 0.40 % is detectable 3-4 months after periodontal therapy received by people with concurrent type 2 diabetes and periodontitis. There may also be increased incidence of diabetes in association with periodontitis which is very undesirable when considering the predicted increase in type 2 diabetes worldwide. Larger-scale clinical trials are required to establish the exact relationship between the conditions, independent of the many confounding factors. The maintenance of periodontal health should be an important part in the overall management of type 2 diabetes to optimise glycaemic control. n
